AVAILABLE MEDICINE FOR Sevelamer

There are no products to list.

Introduction to Sevelamer

The U.S. FDA approved Sevelamer to manage hyperphosphatemia on October 19, 2007. Sevelamer belongs to the medication class known as phosphate binders. Sevelamer is used in the treatment of High phosphate levels in blood. It is used in patients with kidney problems and on dialysis.

How Sevelamer works

Sevelamer inhibits the absorption of phosphate from the intestine and lower the phosphate levels in the blood. Sevelamer inhibits the absorption of phosphate from the intestine and lower the phosphate levels in the blood.

Common side effects of Sevelamer

Abdominal pain
Diarrhea
Flatulence
Vomiting
Constipation
Nausea
Dyspepsia

We adhere to the World Medical Association's ethical standards.

As a pharmaceutical distributor & facilitator, we are registered and audited by the Food Safety and Drug Control Commissionerate, Rajasthan Government in Rajasthan, India, with license numbers DRUG/2022-23/81145 and DRUG/2022-23/81144.